Does ENCORAFENIB Cause Dysgeusia? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Dysgeusia have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.1% of all adverse event reports for ENCORAFENIB.
12
Reports of Dysgeusia with ENCORAFENIB
0.1%
of all ENCORAFENIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Dysgeusia From ENCORAFENIB?
Of the 12 reports, 3 (25.0%) required hospitalization.
Is Dysgeusia Listed in the Official Label?
Yes, Dysgeusia is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CABOZANTINIB S-MALATE (777)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
Which ENCORAFENIB Alternatives Have Lower Dysgeusia Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN